These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38267707)

  • 1. Patient In-Use Stability Testing of FDA-Approved Metformin Combination Products for N-Nitrosamine Impurity.
    Dharani S; Mohamed EM; Rahman Z; Khan MA
    AAPS PharmSciTech; 2024 Jan; 25(1):19. PubMed ID: 38267707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes.
    Dharani S; Mohamed EM; Khuroo T; Ali HI; Reddy IK; Rahman Z; Khan MA
    Int J Pharm; 2022 Jul; 623():121923. PubMed ID: 35750279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
    Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
    AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.
    Georgescu GC; Cretu-Stancu M; Bucur O
    Sci Rep; 2024 Jun; 14(1):13910. PubMed ID: 38886399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines.
    Keire DA; Bream R; Wollein U; Schmaler-Ripcke J; Burchardt A; Conti M; Zmysłowski A; Keizers P; Morin J; Poh J; George M; Wierer M
    AAPS J; 2022 Apr; 24(3):56. PubMed ID: 35449372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Nitrosodimethylamine formation in metformin hydrochloride sustained-release tablets: Effects of metformin and hypromellose used in drug product formulation.
    Hao G; Hu R; Wang X; Gao P; Wang L; Jiang M; Xin L; Tan G; Zhao Y; Sun F; Chu D; Lv J; You J; Huang F; Song X
    J Pharm Biomed Anal; 2023 Jan; 222():115066. PubMed ID: 36191442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
    Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
    Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety vs price in the generic drug market: metformin.
    Teasdale B; Hudspeth A; Kucera K; Light D; Nailor J; Williams S; Milstein A; Schulman KA
    Am J Manag Care; 2024 Apr; 30(4):161-168. PubMed ID: 38603530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?
    Schmidtsdorff S; Neumann J; Schmidt AH; Parr MK
    Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200484. PubMed ID: 36461687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite.
    Schlingemann J; Boucley C; Hickert S; Bourasseau L; Walker M; Celdran C; Chemarin T; Pegues C; Fritzsche M; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Reifenberg P; Wetzel S; Müller T; Schooren F; Schuster T; Liebhold M; Kirsch A; Krueger P; Saal C; Mouton B; Masanes S
    Int J Pharm; 2022 May; 620():121740. PubMed ID: 35421534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products.
    Nasr NEH; Metwaly MG; Ahmed EO; Fares AR; ElMeshad AN
    Expert Opin Drug Saf; 2021 Jul; 20(7):855-862. PubMed ID: 33849366
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zmysłowski A; Książek I; Szterk A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDMA Formation Due to Active Ingredient Degradation and Nitrite Traces in Drug Product.
    Golob N; Peterlin S; Grahek R; Roškar R
    J Pharm Sci; 2023 May; 112(5):1277-1286. PubMed ID: 36925105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDMA analytics in metformin products: Comparison of methods and pitfalls.
    Fritzsche M; Blom G; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Hickert S; Reifenberg P; Cimelli A; Baranowski R; Desmartin E; Barrau E; Harrison M; Bristow T; O'Neill N; Kirsch A; Krueger P; Saal C; Mouton B; Schlingemann J
    Eur J Pharm Sci; 2022 Jan; 168():106026. PubMed ID: 34597792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
    De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
    J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
    Kalauz A; Tiringer KV; Horváth V; Kapui I
    J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of an optimized total N-nitrosamine (TONO) assay to pools: placing N-nitrosodimethylamine (NDMA) determinations into perspective.
    Kulshrestha P; McKinstry KC; Fernandez BO; Feelisch M; Mitch WA
    Environ Sci Technol; 2010 May; 44(9):3369-75. PubMed ID: 20355696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tablets.
    Shakleya D; Alayoubi A; Brown D; Mokbel A; Abrigo N; Mohammad A; Wang J; Li D; Shaklah M; Alsharif FM; Desai S; Essandoh M; Faustino PJ; Ashraf M; O' Connor T; Vera M; Raw A; Sayeed VA; Keire D
    Int J Pharm; 2024 Dec; 666():124832. PubMed ID: 39414182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of nitrosamine impurities in medicinal products.
    Sedlo I; Kolonić T; Tomić S
    Arh Hig Rada Toksikol; 2021 Mar; 72(1):1-5. PubMed ID: 33787187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.